LVOVX
Price
$20.20
Change
-$0.50 (-2.42%)
Updated
Feb 21 closing price
Net Assets
1.27B
VEXAX
Price
$144.57
Change
-$4.57 (-3.06%)
Updated
Feb 21 closing price
Net Assets
116.7B
Ad is loading...

LVOVX vs VEXAX

Header iconLVOVX vs VEXAX Comparison
Open Charts LVOVX vs VEXAXBanner chart's image
Lord Abbett Value Opportunities R6
Price$20.20
Change-$0.50 (-2.42%)
VolumeN/A
Net Assets1.27B
Vanguard Extended Market Index Admiral
Price$144.57
Change-$4.57 (-3.06%)
VolumeN/A
Net Assets116.7B
LVOVX vs VEXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LVOVX vs. VEXAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVOVX is a Buy and VEXAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 117B vs. LVOVX (1.27B). VEXAX pays higher dividends than LVOVX: VEXAX (1.20) vs LVOVX (0.31). LVOVX was incepted earlier than VEXAX: LVOVX (10 years) vs VEXAX (24 years). LVOVX is a more actively managed with annual turnover of: 19.00 vs. VEXAX (11.00). LVOVX has a lower initial minimum investment than VEXAX: LVOVX (0) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 14.31 vs. LVOVX (1.85). VEXAX return over 5 years is better than : 47.41 vs. LVOVX (7.54).
LVOVXVEXAXLVOVX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years24 years-
Gain YTD-1.2710.340-374%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B117B1%
Annual Yield % from dividends0.311.2026%
Returns for 1 year1.8514.3113%
Returns for 3 years-0.8721.16-4%
Returns for 5 years7.5447.4116%
Returns for 10 yearsN/A115.96-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVO12.280.58
+4.96%
Alvotech
WEST6.350.10
+1.60%
Westrock Coffee Company
LPTX0.48N/A
-0.52%
Leap Therapeutics
LPLA372.13-7.33
-1.93%
LPL Financial Holdings
OPRX5.78-0.41
-6.62%
OptimizeRx Corp